Follow Lara Meisner's trades in real time

InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.

START FREE TRIAL →
or open Lara Meisner's full profile on InsiderTape →
Learn how to read insider signals:
Home  /  Insiders  /  Lara Meisner

Lara Meisner Insider Trading Activity

Chief Legal Officer  ·  SEC Form 4 open-market purchases and sales  ·  Sourced from SEC EDGAR

Lara Meisner, Chief Legal Officer, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 18 open-market SEC Form 4 transactions: 0 purchases worth $0 and 18 sales worth $4.0M, reported from Nov 15, 22 to Sep 29, 25. Over this period they have been a net seller.

Buys
0
Sells
18
Buy Value
$0
Companies
2

Lara Meisner's recent insider trades

DateCompanyTypeSharesPriceValue
Sep 29, 25 BCAXBicara Therapeutics Inc. SELL 33.8K $14.75 $499K
Sep 15, 25 BCAXBicara Therapeutics Inc. SELL 15.8K $11.49 $182K
Jun 16, 25 BCAXBicara Therapeutics Inc. SELL 15.8K $10.43 $165K
Mar 14, 25 BCAXBicara Therapeutics Inc. SELL 48.5K $13.24 $616K
Jun 16, 23 VRDNViridian Therapeutics, Inc.\DE SELL 27 $28.35 $765
Jun 15, 23 VRDNViridian Therapeutics, Inc.\DE SELL 2.3K $28.02 $64K
Jun 6, 23 VRDNViridian Therapeutics, Inc.\DE SELL 5.1K $25.02 $128K
Jun 5, 23 VRDNViridian Therapeutics, Inc.\DE SELL 499 $25.03 $12K
Jun 2, 23 VRDNViridian Therapeutics, Inc.\DE SELL 1.9K $24.21 $45K
Mar 9, 23 VRDNViridian Therapeutics, Inc.\DE SELL 30.0K $29.07 $871K
Jan 23, 23 VRDNViridian Therapeutics, Inc.\DE SELL 6.8K $35.66 $244K
Dec 21, 22 VRDNViridian Therapeutics, Inc.\DE SELL 16.3K $29.19 $477K
Dec 20, 22 VRDNViridian Therapeutics, Inc.\DE SELL 600 $28.07 $17K
Dec 16, 22 VRDNViridian Therapeutics, Inc.\DE SELL 1.3K $28.44 $37K
Dec 15, 22 VRDNViridian Therapeutics, Inc.\DE SELL 300 $28.08 $8K
Dec 14, 22 VRDNViridian Therapeutics, Inc.\DE SELL 15.7K $28.12 $440K
Dec 12, 22 VRDNViridian Therapeutics, Inc.\DE SELL 600 $28.05 $17K
Nov 15, 22 VRDNViridian Therapeutics, Inc.\DE SELL 8.1K $22.05 $179K